- The new website is part of MediciGlobal's ongoing efforts to enhance the availability of patient recruitment-retention services to life science professionals worldwide
PHILADELPHIA and LONDON, Jan. 7, 2015 /PRNewswire/ -- MediciGlobal's new website boasts a modern streamlined design that is divided into three sections: recruitment, retention and rescue. Each section provides detailed information on all three aspects of the organization's functioning.
The website also provides social media integration and direct links to MediciGlobal's LinkedIn, Facebook, and YouTube channels, where company and service updates will appear on a regular basis. The site provides numerous ways that visitors can access information from MediciGlobal's 24-year track record of successfully recruiting and retaining patients for clinical trials as well as a section for clinical trials in rescue – ones that are struggling to find patients.
"With clinical trial protocols becoming more complex and requiring niche patient populations, we wanted to highlight that we are the go-to company to rescue these types of clinical trials," said Liz Moench, President and Chief Executive Officer at MediciGroup®. "We needed a website that reflects not only our experience and prowess, but also our passion and purpose. We are truly proud to help patients gain access to the best treatment options possible, and to pave the way for a healthier world, one clinical trial at a time."
She continued, "The rebrand and site overhaul comprised a major undertaking to clearly convey our unique and innovative digital approaches. I believe our new design noticeably communicates that we're not only experienced but we're cutting-edge, and I can't wait to unveil the rest of the website project in 2015."
MediciGlobal is also updating its company marketing collateral to reflect the company's new design and updated approach.
About MediciGroup, Inc.
MediciGroup d/b/a MediciGlobal is a leading full-service provider of clinical trial patient recruitment and retention solutions for the life sciences industry. Its L2FU division (Lost to Follow Up) specializes in locating missing patients to meet regulatory requirements for clinical trials.
Over the past 24 years, MediciGlobal has empowered millions of people with information about clinical trial opportunities that have resulted in new treatments for epilepsy, pain management, depression, anxiety, diabetes, breast and ovarian cancer, and many more. In recent years, MediciGlobal has established more than 30 online patient communities to introduce research opportunities to people affected by these respective conditions, many of which are the largest with global participation. MediciGlobal created these destinations as places to learn about clinical research programs aimed at bringing about new treatments and improving overall health.
Supporting biopharmaceutical companies in over 60 countries with patient-centric programs to accelerate clinical trial enrollment and retention, MediciGlobal meets BBB OnLine® and WBENC accreditation standards (Women-Owned Business) and is certified as a Safe Harbor company.
Visit www.mediciglobal.com to learn more.